KristinaM.DeligiannidisMD

PubMed

• 58 citations
  Zuranolone for the Treatment of Postpartum Depression.
  Kristina M Deligiannidis, Samantha Meltzer-Brody, Bassem Maximos, E Quinn Peeper, Marlene Freeman
  The American Journal of Psychiatry. 2023-09-01
• 113 citations
  Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial.
  Kristina M. Deligiannidis, Samantha Meltzer-Brody, H. Gunduz-Bruce, James J. Doherty, Jeffrey Jonas
  JAMA Psychiatry. 2021-09-01
• 11 citations
  Peripartum depression: Does risk versus diagnostic status impact mother-infant bonding and perceived social support
  Megan M. Hare, Aimee R. Kroll-Desrosiers, Kristina M. Deligiannidis
  Depression and Anxiety. 2021-04-01

Journal Articles

• Expression of inflammatory cytokines across gestation in women with symptoms of perinatal depression  
  Buglione-Corbett R, Deligiannidis KM, Leung K, Zhang NN, Rosal M, Moore Simas TA, Archives of Womens Mental Health, 1/1/2018
• Differential peripartum plasma neuroactive steroid and GABA profiles in healthy women vs women at-risk for developing postpartum depression  
  Deligiannidis KM, Kroll-Desrosiers A, Mo S, Nguyen HP, Svenson A, Jaitly N, Hall JE, Barton BA, Rothschild AJ, Shaffer SA, Psychoneuroendocrinology, 1/1/2016
• Salivary Cortisol Response to the Trier Social Stress Test in Pregnant Women at Risk of Postpartum Depression  
  Deligiannidis KM, Kroll-Desrosiers A, Svenson A, Jaitly, N, Barton BA, Hall JE, Rothschild AJ, Archives of Women�s Mental Health, 1/1/2016
• Prevalence of bipolar disorders and impact on quality of life in a cohort of patients with multiple sclerosis  
  Jun-O�Connell A, Butala A, Berrios-Morales I , Henninger N, Deligiannidis KM, Byatt N, Ionete C, Journal of Neuropsychiatry and Clinical Neurosciences, 1/1/2016
• Gender differences in suicide risk factors among individuals with mood disorders  
  Weiss SJ, Muzik M, Deligiannidis KM, Ammerman RT, Guille C, Flynn HA, Journal of Depression and Anxiety, 1/1/2016
• Heterogeneity of Postpartum Depression: A Latent Class Analysis  
  Putnam KT, Robertson-Blackmore E, Sharkey KM, Payne JL, Bergink V, Munk-Olsen T, Deligiannidis KM, Altemus M, Newport DJ, Apter G, Devouche E, Vikorin A, Magnusson PK,..., Lancet Psychiatry, 1/1/2015
• The physician-scientist workforce in the United States  
  Deligiannidis KM, Acta Psychiatrica Scandinavica, 1/1/2015
• Peripartum depression and anxiety as an integrative cross-domain target for psychiatric preventative measures  
  Babb J, Deligiannidis KM, Murgatroyd C, Nephew NC, Behavioural Brain Research, 1/1/2015
• Implications of the National Institute of Mental Health Research Domain Criteria (RDoC) for researchers and clinicians  
  Ostergaard, SD, Fava M, Rothschild AJ, Deligiannidis KM, Acta Psychiatrica Scandinavica, 1/1/2014
• Complementary and alternative medicine therapies for perinatal depression  
  Deligiannidis KM & Freeman MP, Best Practice & Research Clinical Obstetrics and Gynaecology, 1/1/2014
• Pharmacotherapy for Mood Disorders in Pregnancy: A review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring  
  Deligiannidis KM, Byatt N, Freeman MP, Journal of Clinical Psychopharmacology, 1/1/2014
• A gender analysis of the NIMH Study of the Pharmacotherapy of Psychotic Depression (STOP-PD): Predictors of response and treatment-associated metabolic outcomes  
  Deligiannidis KM, Rothschild AJ, Barton, B., Kroll-Desrosiers, A., Meyers BS, Flint AJ, Whyte, EM, Mulsant BH, Journal of Clinical Psychiatry, 1/1/2013
• Efficacy of the NMDA-antagonist memantine as augmentation treatment for major depression: a double-blind, placebo-controlled trial  
  Smith E., Deligiannidis KM, Ulbricht C, Wogsland C, Patel J, Rothschild AJ, Journal of Clinical Psychiatry, 1/1/2013
• GABAergic neuroactive steroids and disrupted resting-state functional connectivity in postpartum depressed women: A preliminary study  
  Deligiannidis KM, Sikoglu EM, Shaffer, SA, Frederick B, Svenson A, Kopovan A, Kosma C, Rothschild AJ, Moore CM, Journal of Psychiatric Research, 1/1/2013
• Antidepressant Use in Pregnancy: A critical review focused on risks and controversies  
  Byatt N, Deligiannidis KM, Freeman MP, Acta Psychiatrica Scandinavica, 1/1/2013
• Clinical Roundup: How do you treat premenstrual syndrome in your practice?  
  Moore Simas T, Byatt N, Deligiannidis KM, Alternative and Complementary Therapies, 1/1/2011
• The American Society for Clinical Psychopharmacology�s Modules in Depression and Bipolar Disorder: Answering the Call for a Model Curriculum, Original Contribution  
  Prabhakar D, Balon R, Deligiannidis, KM, Zisook S, Revista de Trastornos del Animo, 1/1/2011
• Sex-related differences in antidepressant response: When to adjust treatment  
  Marsh WK, Deligiannidis KM, Current Psychiatry, 1/1/2010
• A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic...  
  Meyers BS, Flint AJ, Rothschild AJ, Mulsant BH, Whyte EM, Peasley-Miklus C, Papademetriou E, Leon AC, Heo M; STOP-PD Group, JAMA Psychiatry, 1/1/2009
• Regulation of Arylalkylamine N-Acetyltransferase-2 in the Fish Pineal Organ: Evidence for a Role of Proteasomal Proteolysis  
  Falcon J, Galarneau KM, Weller JL, Ron B, Chen G, Coon SL, Klein DC, Endocrinology, 1/1/2001
• Join now to see all

Books/Book Chapters

• Biomarkers of Postpartum Psychiatric Disorders 
  Chapter: Functional MRI biomarkers in perinatal psychiatric disorders 
  Hare M, Duan C, Deligiannidis KMEditors: J Payne.Elsevier2018
• The Evidence-Based Guide to Antidepressants 
  Chapter: The use of antidepressants in pregnancy and lactation 
  Deligiannidis KMEditors: AJ Rothschild.American Psychiatric Publishing, Inc., Arlington, VA2012
• The Evidence-Based Guide to Antipsychotics 
  Chapter: The Use of Antipsychotics in Mood and Anxiety Disorders 
  Deligiannidis KM & Rothschild AJEditors: AJ Rothschild.American Psychiatric Publishing, Inc., Arlington, VA2010
• The Evidence-Based Guide to Antipsychotics 
  Chapter: The Use of Antipsychotics in Schizophrenia and Schizoaffective Disorder 
  Patel JK & Deligiannidis KMEditors: AJ Rothschild.American Psychiatric Publishing, Inc., Arlington, VA2010
• Join now to see all

Abstracts/Posters

• Analysis of the efficacy and safety of Brexanolone Injection in subgroups from an integrated dataset of placebo-controlled postpartum depression studies
  40. Meltzer-Brody, S, Kanes S, Riesenberg, Epperson CN, Deligiannidis KM, Rubinow D, Li H, Clemson C, Colquhoun H, World Congress on Women’s Mental Health, International Association for Women’s Mental Health, Paris, France, 3/2019
• Integrated analysis of efficacy as assessed by the Montgomery-Asberg Depression rating scale from three pivotal trials of brexanolone in women with postpartum depression.
  41. Meltzer-Brody, S, Colquhoun H, Riesenberg R, Epperson, CN, Deligiannidis KM, Rubinow D, Li H, Clemson C, Kanes S., 39th Annual Pregnancy Meeting of the Society of Maternal Fetal Medicine,, Las Vegas, NV, 2/2019
• Efficacy and Safety of Brexanolone IV, a GABA-A Receptor Modulator, in Women with Postpartum Depression
  Meltzer-Brody, S, Colquhoun H, Riesenberg R, Epperson, CN, Deligiannidis KM, Rubinow D, Li H, Clemson C, Kanes S, International Marce Society Biennial Scientific Meeting, Bangalore, India, 1/1/2018
• Phase 2 and 3 Evaluation of Brexanolone, a GABAA Receptor Positive Allosteric Modulator, in Postpartum Depression
  Meltzer-Brody, S, Colquhoun H, Riesenberg R, Epperson CN, Maximos B, Harrison H, Jagadeesan S, Deligiannidis KM, Li H, Clemson C, Kanes S, Society for Maternal Fetal Medicine 38th Annual Meeting, Dallas, TX, 1/1/2018
• Efficacy and Safety of Brexanolone iv in Hummingbird 202C: a Double-blind, Placebo-controlled Phase 3 Study in Postpartum Depression
  Meltzer-Brody, S, Kanes S, Riesenberg, Epperson CN, Deligiannidis KM, Rubinow D, Li H, Clemson C, Colquhoun H, Annual Meeting of the 73rd Annual Conference of the Society of Biological Psychiatry, New York, NY, 1/1/2018
• Efficacy and Safety of Brexanolone iv Across Hummingbird B and C Studies: a First-in-class GABAA Receptor Positive Allosteric Modulator for Postpartum Depression
  Meltzer-Brody, S, Kanes S, Riesenberg, Epperson CN, Deligiannidis KM, Rubinow D, Li H, Clemson C, Colquhoun H, Annual Meeting of the 73rd Annual Conference of the Society of Biological Psychiatry, New York, NY, 1/1/2018
• Functional connectivity, cortical GABA and neuroactive steroids in peripartum and peripartum depressed women
  Deligiannidis KM, Fales, CL, Kroll-Desrosiers, Shaffer SA, Villamarin V, Tan Y, Hall JE, Frederick BB, Sikoglu EM, Edden RA, Rothschild, AJ, Moore CM, American College of Neuropsychopharmacology (ACNP) 57th Annual Meeting, Hollywood, FL, 1/1/2018
• Efficacy and Safety of Brexanolone iv Across Phase 2/3 Studies: a First-in-class GABAA Receptor Positive Allosteric Modulator for Postpartum Depression
  Meltzer-Brody, S, Kanes S, Riesenberg, Epperson CN, Deligiannidis KM, Rubinow D, Li H, Clemson C, Colquhoun H, 31st Annual Postpartum Support International Conference, Houston, TX, 1/1/2018
• Efficacy and Safety of Brexanolone iv in Hummingbird 202B: a Double-blind, Placebo-controlled Phase 3 Study in Postpartum Depression
  Meltzer-Brody, S, Kanes S, Riesenberg, Epperson CN, Deligiannidis KM, Rubinow D, Li H, Clemson C, Colquhoun H, Annual Meeting of the 73rd Annual Conference of the Society of Biological Psychiatry, New York, NY, 1/1/2018
• Brexanolone a GABAA Receptor Positive Allosteric Modulator, in Postpartum Depression: Phase 2 and Phase 3 Evaluation
  Meltzer-Brody, S, Colquhoun H, Riesenberg R, Epperson CN, Maximos B, Harrison H, Jagadeesan S, Deligiannidis KM, Li H, Clemson C, Kanes S, Biennial Perinatal Mental Health Conference, Chicago, IL, 1/1/2017
• Phase 2 and 3 Studies Evaluating Brexanolone iv, a GABAA Receptor Positive Allosteric Modulator, in Postpartum Depression
  Meltzer-Brody S, Colquhoun H, Riesenberg R, Epperson CN, Maximos B, Harrison H, Jagadeesan S, Deligiannidis KM, Li H, Clemson C, Kanes S, American College of Neuropsychopharmacology (ACNP) 56th Annual Meeting, Palm Springs, CA, 1/1/2017
• A Microgenetic Study of Parental Depression and Infant Development at 3 Months Postpartum
  Kalpidou M, doCurral A, Kuersten-Hogan R, Deligiannidis KM, Society for Research in Child Development Biennial Meeting, Austin, TX, 1/1/2017
• Phase 2 Randomized Controlled Trial of SAGE-547 in Postpartum Depression
  Kanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, Doherty J, Epperson CN, Deligiannidis KM, Riesenberg R, Hoffman E, Jonas J, Meltzer-Brody S, College of Psychiatric & Neurologic Pharmacists Annual Meeting, Phoenix, AZ, 1/1/2017
• 30-day remission rates in severe postpartum depression: secondary endpoints from a Phase 2 trial of SAGE-547 Injection
  Kanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, Doherty J, Epperson CN, Deligiannidis KM, Riesenberg R, Hoffman E, Jonas J, Meltzer-Brody S, American Psychiatric Association (APA) Annual Meeting, San Diego, CA, 1/1/2017
• Disrupted Resting-State Functional Connectivity in Medication-free Women with Postpartum Depression and Anxiety
  Deligiannidis KM, Fales CL, Villamarin V, Jaitly N, Hall JE, Schmidt PJ, Frederick BB, Rothschild AJ, Moore CM, American College of Neuropsychopharmacology (ACNP) 56th Annual Meeting, Palm Springs, CA, 1/1/2017
• Kroll-Desrosiers AR, Nephew BC, Babb JA, Guilarte-Walker Y, Moore Simas TA, Deligiannidis KM
  Kroll-Desrosiers AR, Nephew BC, Babb JA, Guilarte-Walker Y, Moore Simas TA, Deligiannidis KM, Postpartum Support International Annual Meeting, Philadelphia, PA, 1/1/2017
• White matter integrity in medication-free women with peripartum depression: diffusion tensor imaging study using tract-based spatial statistics
  Silver M, Moore CM, Villamarin V, Jaitly, N, Hall JE, Frederick BB, Rothschild AJ, Deligiannidis KM, Society of Biological Psychiatry (SOBP) 72nd Annual Scientific Meeting, San Diego, CA, 1/1/2017
• Assessment of clinical endpoints and categorical response measures in a Phase 2 trial of SAGE-547 Injection in postpartum depression
  Kanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, Doherty J, Epperson CN, Deligiannidis KM, Riesenberg R, Hoffman E, Jonas J, Meltzer-Brody S, American Psychiatric Association (APA) Annual Meeting, San Diego, CA, 1/1/2017
• Comparison of the Use of the EPDS-3 vs. the EPDS-10 to Identify Women at-risk for Peripartum Depression
  Bodenlos K, Maranda L, Deligiannidis KM, American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting, Washington, DC, 1/1/2016
• Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year
  Kroll-Desrosiers AR, Nephew BC, Babb JA, Guilarte-Walker Y, Moore Simas TA, Deligiannidis KM, American College of Neuropsychopharmacology (ACNP) 55th Annual Meeting, Hollywood, FL, 1/1/2016
• Neuroscience Education for Psychiatrists: Unmet Needs and New SOBP Initiatives
  Carlson PJ, Deligiannidis KM, Drazinic C, Holtzheimer PE, Postolache TT, Society of Biological Psychiatry Education Committee, Pittinger C, Association for Academic Psychiatry Annual Meeting, San Antonio, TX, 1/1/2015
• Rapid Ultrasensitive High Precision LC-MS Assays Identify Unique Neuroactive Steroid and GABA Profiles in Women at-risk for Postpartum Depression
  Deligiannidis KM, Kroll-Desrosiers AR, Mo S, Nguyen HP, Svenson A, Jaitly N, Hall JE, Barton BA, Rothschild AJ, Shaffer SA, American College of Neuropsychopharmacology (ACNP) 54th Annual Meeting, Hollywood, FL, 1/1/2015
• Expression of Inflammatory Markers in Women with Symptoms of Perinatal Depression
  Buglione-Corbett R, Deligiannidis KM, Leung K, Zhang NN, Rosal M, Moore Simas TA, Reproductive Sciences, 1/1/2015
• A Novel and Rapid Ultrasensitive High Precision LC-MS Assay for Assessment of Plasma GABAergic Neuroactive Steroids in Psychiatric Disorders
  Shaffer SA, Mo S, Deligiannidis, KM, Society of Biological Psychiatry 70th Annual Meeting; Biological Psychiatry, Toronto, Canada, 1/1/2015
• Prevalence of Bipolar Disorders and Impact on Quality of Life in a Cohort of Patients with Multiple Sclerosis
  Berrios-Morales I, Jun-O�Connell A, Butala A, Ahlawat A, Deligiannidis KM, Byatt N, Henninger N, Ionete C, European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 31st Annual Congress, Barcelona, Spain, 1/1/2015
• Join now to see all

Lectures

• Peripartum Depression: Clinical Update and New Research into Pathophysiology and Treatment 
  New Hyde Park, NY - 1/1/2018
• Clinical Update on the Presentation and Treatment of Peripartum Depression 
  Zucker Hillside Hospital, Glen Oaks, NY - 1/1/2018
• Inflammation and the Development of Perinatal Mood and Anxiety Disorders 
  Manhasset, NY - 1/1/2018
• Neuroactive steroids and GABA in peripartum depression 
  San Diego, CA - 1/1/2017
• Management of Postpartum Depression: Role of SAGE-547 Injection in the Treatment of Adult Female Subjects with Moderate or Severe Postpartum Depression 
  Zucker Hillside Hospital, Glen Oaks, NY - 1/1/2017
• New Peripartum Mood Disorder Research at Northwell: Integrating our clinical, research and education missions 
  Zucker Hillside Hospital, Glen Oaks, NY - 1/1/2017
• GABA Magnetic Resonance Spectroscopy: Furthering knowledge of neurobiological mechanisms from neuromaturation to psychopathology 
  Atlanta, GA - 1/1/2016
• Neuroendocrine factors in women with depression 
  Hoagland-Pincus Center, UMass Medical School, Shrewsbury, MA - 1/1/2016
• Cortical GABA in Peripartum Depression 
  New York, NY - 1/1/2016
• Translational Neuroendocrine and Neuroimaging Research in Peripartum Depression. A focus on neuroactive steroids and interactions with the GABAergic system 
  Belmont, MA, 2015; University of Maryland School of Medicine, Baltimore, MD, 2015; Columbia Universi - 1/1/2015
• A cross-cultural study of postpartum depression 
  Northwestern University, Chicago, IL - 1/1/2015
• Implications of biomarkers for prevention, diagnosis and treatment of peripartum depression 
  Northwestern University, Chicago, IL - 1/1/2015
• Translational Neuroendocrine and Neuroimaging Research in Peripartum Depression 
  Beth Israel Deaconess Medical Center, Boston, MA, 2015; Zucker Hillside Hospital, North Shore/Long I - 1/1/2015
• Translational Neuroendocrine and Neuroimaging Research in Peripartum Depression: A focus on neurosteroids and the GABAergic system 
  New York, NY - 1/1/2015
• Perinatal depression research: from pathogenesis to treatment 
  Worcester, MA - 1/1/2015
• Update on the Psychopharmacologic Treatment of Major Depressive Disorder 
  Worcester, MA - 1/1/2014
• Schizophrenia and Bipolar Disorder Individual Research Reports 
  Hollywood, FL - 1/1/2014
• Neuroimaging Research in Postpartum Depression 
  Worcester, MA - 1/1/2014
• New insights into perinatal depression:from pathogenesis to treatment 
  Hanover, NH - 1/1/2014
• Recruiting, retaining and evaluating pregnant and postpartum subjects in mental health research 
  1/1/2013
• New investigations into gender differences in depressive disorders: from pathophysiology to clinical presentation to treatment 
  Ann Arbor, MI - 1/1/2013
• Non-pharmacological Treatment Interventions for Perinatal Depression/Nutriceuticals in the Treatment of Perinatal Depression 
  San Francisco, CA - 1/1/2013
• Evidence Based Practice for Postpartum Depression and Anxiety: Assessment, Triage and Treatment 
  Franklin Medical Center, Greenfield, MA - 1/1/2012
• Neuroendocrine and Neuroimaging Endophenotypes in Perinatal Depression: Disrupted resting-state functional connectivity and the role of neuroactive steroids in perinat... 
  Worcester, MA - 1/1/2012
• Perinatal Depression: Addressing the needs of mother and child 
  Baystate Medical Center/Tufts University School of Medicine, Springfield, MA - 1/1/2012
• Join now to see all

Other

• From Joy to Anguish: Depression among new mothers gets much-needed attention 
  Beil L
  https://www.sciencenews.org/article/postpartum-depression-scientific-research-mothers
  1/17/2018
• Is postpartum depression a unique psychiatric disorder? 
  Zagorski, N, Psychiatric News
  https://psychnews.psychiatryonline.org/doi/10.1176/appi.pn.2018.4a14
  1/4/2018
• Postpartum Psychosis: Symptoms, Treatment and Who�s at Risk 
  Willets M
  https://www.parents.com/baby/health/postpartum-depression/postpartum-psychosis-symptoms-treatment-and-whos-at-risk
  1/1/2018
• Feinstein�s Unexpected Postpartum Blessing 
  Zeller G
  www.innovateli.com/
  1/30/2017
• Exposure to synthetic oxytocin may increase risk of postpartum depression, anxiety 
  Psychiatric News Alert
  http://alert.psychnews.org/2017/01/exposure-to-synthetic-oxytocin-may.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+PsychiatricNewsAlert+%28Psychiatric+News+Alert%29
  1/30/2017
• Feinstein Institute study finds medication commonly used during labor associated with postpartum depression 
  Port Washington News
  http://portwashington-news.com/port-washington-area-news/?rkey=20170130DC99469&filter=6940
  1/30/2017
• A link between accelerated delivery and depression/Un lien entre accouchement accelere et depression? 
  Thibert C, Le Figaro
  www.lefigaro.fr
  1/12/2017
• Common labor medication associated with postpartum depression 
  CBS NY TV2
  http://newyork.cbslocal.com/2017/02/06/post-partum-depression/
  1/6/2017
• New study shows link between pitocin and postpartum depression 
  NPR�s WSHU, Fairfield CT Public Radio
  http://app.criticalmention.com/app/#clip/view/26002585?token=804f5298-83ee-40b2-b165-48c44492e9fc
  1/3/2017
• LI doctor links drug given to mothers to postpartum depression 
  Ricks D, Newsday
  www.newsday.com/
  1/1/2017
• Oxytocin during labor linked to increased risk of postpartum depression 
  
  https://medicalresearch.com/author-interviews/oxytocin-during-labor-linked-to-increased-risk-of-postpartum-depression/31674/
  1/1/2017
• Are hormones are genes to blame for peripartum depression 
  Malicka Marshall, WBZ CBS TV4
  http://boston.cbslocal.com/2016/05/13/peripartum-depression-hormones-genes/
  Boston, MA - 1/13/2016
• Practical advice from working researchers 
  Deligiannidis KM
  http://www.4researchers.org/contributors
  1/1/2014
• Postpartum depression 
  Butler, G, Pregnancy & Newborn Magazine
  http://www.pnmag.com/
  1/1/2014
• Mentorship is the Key to Success 
  Deligiannidis KM
  http://www.4researchers.org/contributors
  1/1/2014
• Good Mentees Take an Active Role 
  Deligiannidis KM
  http://www.4researchers.org/contributors
  1/1/2014
• CTSA Awards are Steppingstones towards Larger Studies 
  Deligiannidis KM
  http://www.4researchers.org/contributors
  1/1/2014
• Advantages of K23 Awards vs. R-Type Mechanisms 
  Deligiannidis KM
  http://www.4researchers.org/contributors
  1/1/2014
• When the �baby blues� are something more 
  Weintraub K
  http://www.bostonglobe.com/lifestyle/health-wellness/2013/10/20/depression-common-new-mothers-and-can-increase-child-risk-later-becoming-depressed-themselves/ZdEEAnDOngMQTOXPJimxoN/story.html
  1/21/2013
• Brain and hormone research focuses on depression in new mothers 
  Deligiannidis KM
  http://www.youtube.com/watch?v=cDJbBhG6d88
  1/21/2013
• Research targets preventing postpartum depression in new moms 
  WCVB TV5
  http://www.wcvb.com/health/research-targets-preventing-postpartum-depression-in-new-moms/-/9848730/21548292/-/29unhwz/-/index.html
  Boston, MA - 1/20/2013
• Winter�s dark makes some especially SAD 
  Goodchild B
  http://www.umassmed.edu/news/2013/education/winters-dark-makes-some-especially-sad.aspx
  1/16/2013
• Complementary and Alternative Medicine Therapies for Depression in Pregnancy 
  Deligiannidis KM, ObGyn.net
  http://hcp.obgyn.net/pregnancy-and-birth/content/article/1760982/2148534
  1/1/2013
• The SAD season 
  Rough J, Bethesda Magazine
  http://www.bethesdamagazine.com/Bethesda-Magazine/January-February-2012/The-SAD-Season/
  1/1/2012
• Study uses brain imaging to understand postpartum depression 
  Fessenden J & B. Goodchild
  http://www.umassmed.edu/news/research/2011/understanding-postpartum-depression.aspx
  1/22/2011
• Join now to see all